Henry Schein, Inc. (HSIC)
NASDAQ: HSIC · Real-Time Price · USD
70.47
+1.83 (2.67%)
At close: May 12, 2025, 4:00 PM
69.12
-1.35 (-1.92%)
After-hours: May 12, 2025, 6:14 PM EDT
Henry Schein Market Cap
Henry Schein has a market cap or net worth of $8.58 billion as of May 12, 2025. Its market cap has decreased by -8.83% in one year.
Market Cap
8.58B
Enterprise Value
11.67B
1-Year Change
-8.83%
Ranking
Category
Stock Price
$70.47
Market Cap Chart
Since December 1, 1998, Henry Schein's market cap has increased from $1.43B to $8.58B, an increase of 500.84%. That is a compound annual growth rate of 7.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 8.35B | -3.17% |
Dec 31, 2024 | 8.63B | -12.30% |
Dec 29, 2023 | 9.84B | -9.13% |
Dec 30, 2022 | 10.83B | 0.70% |
Dec 31, 2021 | 10.75B | 12.63% |
Dec 31, 2020 | 9.55B | -2.50% |
Dec 31, 2019 | 9.79B | -18.20% |
Dec 31, 2018 | 11.97B | 9.13% |
Dec 29, 2017 | 10.97B | -10.18% |
Dec 30, 2016 | 12.21B | -6.91% |
Dec 31, 2015 | 13.12B | 14.41% |
Dec 31, 2014 | 11.47B | 16.88% |
Dec 31, 2013 | 9.81B | 38.62% |
Dec 31, 2012 | 7.08B | 21.55% |
Dec 30, 2011 | 5.82B | 2.78% |
Dec 31, 2010 | 5.66B | 19.02% |
Dec 31, 2009 | 4.76B | 45.17% |
Dec 31, 2008 | 3.28B | -40.37% |
Dec 31, 2007 | 5.50B | 26.72% |
Dec 29, 2006 | 4.34B | 14.05% |
Dec 30, 2005 | 3.80B | 26.25% |
Dec 31, 2004 | 3.01B | 2.15% |
Dec 31, 2003 | 2.95B | 48.97% |
Dec 31, 2002 | 1.98B | 25.28% |
Dec 31, 2001 | 1.58B | 9.84% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 682.08B |
Johnson & Johnson | 372.82B |
UnitedHealth Group | 342.98B |
AbbVie | 339.27B |
Novo Nordisk | 292.03B |
Abbott Laboratories | 230.60B |
Novartis AG | 213.30B |
AstraZeneca | 211.14B |